1. OP0205 Clinical and Preclinical Assessment of The Anti-MCAM Monoclonal Antibody PRX003, A Potential Novel Treatment for Th17-Mediated Inflammatory Diseases. (15th July 2016) Authors: Koller, M.; Flanagan, K.; Skov, M.; Goldblum, R.; Griffith, S.G.; Barbour, R.M.; Ehsani-Chimeh, N.; Marinkovich, M.P.; Zago, W.; Yednock, T.A.; Kinney, G.G.; Ness, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗